Bausch Health Companies Inc (NYSE:BHC)
| 30.25 Delayed Data As of Jan 17 |  +0.50 / +1.68%Today’s Change | 18.72 Today|||52-Week Range 31.97 | +1.10% Year-to-Date |
Latest BHC News | Press Releases
| Why Bausch Health Companies Stock Gained 62% in 2019 Jan 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 29.75 |
| Today’s open | 29.94 |
| Day’s range | 29.77 - 30.39 |
| Volume | 5,212,621 |
| Average volume (3 months) | 3,873,682 |
| Market cap | $9.7B |
Data as of 6:30pm ET, 01/17/2020
Growth & Valuation
| Earnings growth (last year) | -272.12% |
| Earnings growth (this year) | +8.52% |
| Earnings growth (next 5 years) | +6.30% |
| Revenue growth (last year) | -3.94% |
| P/E ratio | NM |
| Price/Sales | 0.77 |
| Price/Book | 3.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MYLMylan NV | -0.31 | -1.41% |
| SRPTSarepta Therapeutics... | -2.40 | -1.84% |
| CTLTCatalent Inc | -0.59 | -0.96% |
| JAZZJazz Pharmaceuticals... | -0.54 | -0.36% |
Data as of 6:30pm ET, 01/17/2020
Financials
| Next reporting date | March 2, 2020 |
| EPS forecast (this quarter) | $1.14 |
| Annual revenue (last year) | $8.4B |
| Annual profit (last year) | -$4.1B |
| Net profit margin | -49.50% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
No executives to display |
Corporate headquarters Laval, Quă©bec |
Forecasts
